These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1003214

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Protriptyline induced inhibition of the in vivo 3H-noradrenaline synthesis from 3H-L-dopa in the rat brain.
    Nielsen M, Eplov L, Scheel-Krüger J.
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):15-28. PubMed ID: 4280017
    [No Abstract] [Full Text] [Related]

  • 23. [Attempt at potentiation of the action of L-dopa on the secretion of growth hormone by benserazide, disulfiram and propranolol].
    Rochiccioli P, Enjaume P, Dutau G, Ribot C, Augier D.
    Arch Fr Pediatr; 1976 Jan; 33(1):55-66. PubMed ID: 985031
    [Abstract] [Full Text] [Related]

  • 24. Mechanisms involved in the prolactin-releasing effect of benserazide.
    Parati EA, Penalva A, Bondiolotti GP, Parenti M, Locatelli V, Picotti GB, Cocchi D, Müller EE.
    Eur J Pharmacol; 1984 Jun 01; 101(3-4):215-21. PubMed ID: 6468496
    [Abstract] [Full Text] [Related]

  • 25. Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
    Pontiroli AE, Castegnaro E, Vettaro MP, Viberti GC, Pozza G.
    Acta Endocrinol (Copenh); 1977 Jan 01; 84(1):36-44. PubMed ID: 318788
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. On the brain monoaminergic systems relating to ejaculation. III) Further study by using a peripheral decarboxylase inhibitor.
    Kimura Y, Miyamoto A, Tadano T, Harada T, Kisara K.
    Andrologia; 1980 Jan 01; 12(4):354-9. PubMed ID: 7191642
    [Abstract] [Full Text] [Related]

  • 32. Nicotinic acid or N-methyl nicotinamide prolongs elevated brain dopa and dopamine in L-dopa treatment.
    Black MJ, Brandt RB.
    Biochem Med Metab Biol; 1986 Oct 01; 36(2):244-51. PubMed ID: 2946308
    [Abstract] [Full Text] [Related]

  • 33. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
    Maj J, Pawlowski L, Sarnek J.
    Adv Biochem Psychopharmacol; 1974 Oct 01; 10():253-6. PubMed ID: 4846541
    [No Abstract] [Full Text] [Related]

  • 34. Reduction of hypoxia-induced disturbances by previous treatment with benserazide and L-dopa in rats.
    Boismare F, le Poncin M, Belliard JP, Hacpille L.
    Experientia; 1975 Oct 15; 31(10):1190-1. PubMed ID: 1204736
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of tyrosine-3-monooxygenase by benserazide.
    Reinhard JF, Shearin MD.
    Biochem Pharmacol; 1990 May 01; 39(9):1489-91. PubMed ID: 1970732
    [No Abstract] [Full Text] [Related]

  • 36. [Effect of L-dihydroxyphenylalanine on rat behavior and on catecholamine metabolism of the brain in rats with different degrees of emotional-behavioral reactivity].
    Bondarenko NA, Miroshnichenko II, Kudrin VS, Bondarenko NA.
    Biull Eksp Biol Med; 1988 Aug 01; 106(8):168-70. PubMed ID: 3416051
    [Abstract] [Full Text] [Related]

  • 37. Ethanol, levodopa and inhibitors of extracerebral aromatic L-amino acid decarboxylase: a drug-drug interaction study.
    Messiha FS.
    Proc West Pharmacol Soc; 1977 Aug 01; 20():327-31. PubMed ID: 896840
    [No Abstract] [Full Text] [Related]

  • 38. Levodopa pharmacokinetics. Alterations after benserazide, a decarboxylase inhibitor.
    Doller HJ, Connor JD, Lock DR, Sloviter RS, Dvorchik BH, Vesell ES.
    Drug Metab Dispos; 1978 Aug 01; 6(2):164-8. PubMed ID: 26532
    [Abstract] [Full Text] [Related]

  • 39. Microdialysis monitoring of 3,4-dihydroxyphenylalanine accumulation after decarboxylase inhibition: a means to estimate in vivo changes in tyrosine hydroxylase activity of the rat locus ceruleus.
    Robert F, Lambás-Señas L, Ortemann C, Pujol JF, Renaud B.
    J Neurochem; 1993 Feb 01; 60(2):721-9. PubMed ID: 8093483
    [Abstract] [Full Text] [Related]

  • 40. Effect of benserazide on the levels of pineal 5-hydroxytryptamine, melatonin synthesising enzymes and serum melatonin.
    Ho AK, Smith JA.
    Biochem Pharmacol; 1982 Jul 01; 31(13):2251-5. PubMed ID: 6889864
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.